Thrivent Financial for Lutherans’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-42,435
| Closed | -$285K | – | 2429 |
|
2023
Q2 | $285K | Sell |
42,435
-2,082
| -5% | -$14K | ﹤0.01% | 2335 |
|
2023
Q1 | $393K | Sell |
44,517
-248,226
| -85% | -$2.19M | ﹤0.01% | 2217 |
|
2022
Q4 | $2.24M | Buy |
292,743
+4,196
| +1% | +$32K | 0.01% | 1183 |
|
2022
Q3 | $2.05M | Buy |
288,547
+13,787
| +5% | +$98.1K | 0.01% | 1200 |
|
2022
Q2 | $2.22M | Sell |
274,760
-18,196
| -6% | -$147K | 0.01% | 1174 |
|
2022
Q1 | $4.07M | Sell |
292,956
-294,814
| -50% | -$4.09M | 0.01% | 962 |
|
2021
Q4 | $16.5M | Buy |
587,770
+24,508
| +4% | +$688K | 0.03% | 524 |
|
2021
Q3 | $19.1M | Buy |
563,262
+14,086
| +3% | +$479K | 0.04% | 476 |
|
2021
Q2 | $22.4M | Buy |
549,176
+111,051
| +25% | +$4.54M | 0.05% | 426 |
|
2021
Q1 | $17.6M | Buy |
+438,125
| New | +$17.6M | 0.04% | 483 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 2153 |
|